Amylyx Pharmaceuticals (AMLX) Stock Chart & Stock Price History $5.71 -0.05 (-0.94%) As of 10:59 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Amylyx Pharmaceuticals Stock Price Performance The Amylyx Pharmaceuticals (AMLX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 230.75%, with a year-to-date return of 52.25%. In the past month, the stock has increased 24.84%, reflecting recent market activity. As of the latest close, Amylyx Pharmaceuticals traded at $5.76 with a market cap of $513.45 million and volume of 1.39 million shares. Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.97%1 Month Performance+24.84%3 Month Performance+54.29%Year-To-Date Performance+52.25%1 Year Performance+230.75% AMLX Stock Chart for Wednesday, June, 11, 2025 AMLX Chart by TradingView Amylyx Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/10/2025$5.44$5.76+5.88%$5.90$5.431.39 million shs$513.45 million06/09/2025$5.33$5.44+2.06%$5.48$5.24588,871 shs$484.93 million06/06/2025$5.05$5.33+5.54%$5.34$4.99757,278 shs$475.12 million06/05/2025$4.92$5.05+2.64%$5.07$4.76693,014 shs$450.16 million06/04/2025$5.12$4.92-3.91%$5.12$4.90536,561 shs$438.57 million06/03/2025$5.10$5.12+0.39%$5.32$4.981.01 million shs$456.40 million06/02/2025$5.23$5.10-2.49%$5.20$4.84795,928 shs$454.62 million05/30/2025$4.90$5.23+6.73%$5.33$4.711.37 million shs$466.21 million05/29/2025$4.79$4.90+2.30%$4.92$4.71550,620 shs$436.79 million05/28/2025$4.72$4.79+1.48%$4.83$4.64498,233 shs$426.99 million Get the Latest News and Ratings for AMLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/27/2025$5.31$4.72-11.11%$5.40$4.691.02 million shs$420.75 million05/26/2025$5.31$5.31$5.38$5.09906,493 shs$473.34 million05/23/2025$5.36$5.31-0.93%$5.38$5.09906,493 shs$473.34 million05/22/2025$5.43$5.36-1.29%$5.50$5.25916,784 shs$477.80 million05/21/2025$5.52$5.43-1.63%$5.55$5.19755,558 shs$484.04 million05/20/2025$5.36$5.52+2.99%$5.54$5.221.58 million shs$492.06 million05/19/2025$4.84$5.36+10.74%$5.48$4.712.00 million shs$477.80 million05/16/2025$4.52$4.84+7.08%$4.86$4.47798,017 shs$431.44 million05/15/2025$4.35$4.52+3.91%$4.54$4.27446,268 shs$402.66 million05/14/2025$4.49$4.35-3.12%$4.60$4.20479,656 shs$387.52 million05/13/2025$4.60$4.49-2.39%$4.65$4.28893,384 shs$399.99 million05/12/2025$4.61$4.60-0.22%$4.95$4.601.06 million shs$409.79 million Related Companies IDEAYA Biosciences Stock Chart Schrödinger Stock Chart Indivior Stock Chart Galapagos Stock Chart Apogee Therapeutics Stock Chart Beam Therapeutics Stock Chart Immunocore Stock Chart Tarsus Pharmaceuticals Stock Chart Bausch Health Companies Stock Chart Disc Medicine Stock Chart Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMLX) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
